Hypertension Clinical Trials

Showing 3061-3080 of 3,518 trials

MorbiMortality Amelioration in Preeclamptic Primiparas Study. MoMA Pre Prim Study

NCT00763672

The purpose of this study is to determine whether close monitoring of patients with a high sFlt1 plasma level between 25 and 28 weeks of gestation (i.e. at high risk of subsequent preeclampsia) improves maternal and fetal outcomes. The investigator hypothesize that 1/ early screening for preeclampsia by plasmatic sFlt1 will reduce maternal and fetal mortality and morbidity and 2/ a simple urinary PlGF screening will be effective.

PregnancyPrimiparityHypertension+2 more

Assistance Publique - Hôpitaux de Paris1,040 participantsStarted Nov 2008

Paris, France

COMPLETEDPhase 3

Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT00872651

Eligible patients will be randomized in a 1.1 ratio to receive Travoprost 0.004%/timolol 0.5% once daily or Latanoprost 0.005%/Timolol 0.5% once a day for 8 Weeks. The study treatments will be compared for mean diurnal intraocular pressure (IOP) change from baseline at Week 8. Safety parameters measured at 4 study visits: ocular signs, visual acuity, dilated fundus, cardiovascular parameters (blood pressure and pulse), and adverse events.

Open-angle GlaucomaOcular Hypertension

Alcon Research242 participantsStarted Jan 2010

Guangzhou, Guangdong, China

COMPLETEDNA

Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect

NCT01491867

Continuous intraocular pressure (IOP) measurement with a contact lens sensor may provide more information on the drug-related IOP change than 24-hour IOP measurement with Goldmann applanation tonometry (GAT.

GlaucomaOcular Hypertension

Semmelweis University9 participantsStarted Dec 2011

Budapest, Pest County, Hungary • Budapest, Hungary

MorbiMortality Amelioration in Preeclamptic Primiparas Study. MoMA Pre Prim Study

Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension

Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect

Related Searches

Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes

Hemodynamics, Salt Sensitivity and Body Composition in Patients With Morbid Obesity

The DINE Study-Diet Intervention to Negate Diabetes Study (Improving Weight Loss Outcomes for African Americans)

Progression From Impaired Fasting Glucose to Type 2 Diabetes Mellitus Among Subjects With and Without Hypertension in Primary Care Setting

Prehypertension and Dietary Supplements - The PYRAMIDS Study

A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects

A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure.

The Influence of Red Grape Cells on Blood Pressure Vascular Function in People With Hypertension

Nitric Oxide Mediated Vasodilatory Response to Hawthorn Standardized Extract

Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia

SPHERIC-1. Sildenafil and Pulmonary HypERtension In COPD

FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

Relationship of Urine Sodium Excretion to Central Blood Pressure and Aortic Pulse Wave Velocity

Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)

Effect of Gene Variants on Dopamine Receptor Natriuretic Responses

CPAP and Nebivolol in Hypertensive Obstructive Sleep Apnea (OSA) Patients.

A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)